questionsmedicales.fr
Thérapeutique
Traitement médicamenteux
Systèmes de délivrance de médicaments
Systèmes de délivrance de médicaments : Questions médicales fréquentes
Diagnostic
2
Biodisponibilité
Études cliniques
Pharmacocinétique
Libération contrôlée
Symptômes
2
Réaction allergique
Douleur
Effets secondaires
Absorption
Prévention
2
Surveillance
Éducation des patients
Instructions médicales
Adhésion au traitement
Traitements
2
Systèmes injectables
Systèmes transdermiques
Nanoparticules
Délivrance ciblée
Complications
2
Infections
Réactions allergiques
Effets secondaires
Ajustement du traitement
Facteurs de risque
2
Mode de vie
Absorption des médicaments
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Systèmes de délivrance de médicaments : Questions médicales les plus fréquentes",
"headline": "Systèmes de délivrance de médicaments : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Systèmes de délivrance de médicaments : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-18",
"dateModified": "2026-06-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Systèmes de délivrance de médicaments"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Traitement médicamenteux",
"url": "https://questionsmedicales.fr/mesh/D004358",
"about": {
"@type": "MedicalCondition",
"name": "Traitement médicamenteux",
"code": {
"@type": "MedicalCode",
"code": "D004358",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Préparations à action retardée",
"alternateName": "Delayed-Action Preparations",
"url": "https://questionsmedicales.fr/mesh/D003692",
"about": {
"@type": "MedicalCondition",
"name": "Préparations à action retardée",
"code": {
"@type": "MedicalCode",
"code": "D003692",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319.300.253"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vecteurs de médicaments",
"alternateName": "Drug Carriers",
"url": "https://questionsmedicales.fr/mesh/D004337",
"about": {
"@type": "MedicalCondition",
"name": "Vecteurs de médicaments",
"code": {
"@type": "MedicalCode",
"code": "D004337",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319.300.380"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Système d'administration de médicaments à base de nanoparticules",
"alternateName": "Nanoparticle Drug Delivery System",
"url": "https://questionsmedicales.fr/mesh/D000090783",
"about": {
"@type": "MedicalCondition",
"name": "Système d'administration de médicaments à base de nanoparticules",
"code": {
"@type": "MedicalCode",
"code": "D000090783",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319.300.380.800"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Véhicules pharmaceutiques",
"alternateName": "Pharmaceutical Vehicles",
"url": "https://questionsmedicales.fr/mesh/D014677",
"about": {
"@type": "MedicalCondition",
"name": "Véhicules pharmaceutiques",
"code": {
"@type": "MedicalCode",
"code": "D014677",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319.300.754"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Systèmes de délivrance de médicaments",
"alternateName": "Drug Delivery Systems",
"code": {
"@type": "MedicalCode",
"code": "D016503",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Qin Shi",
"url": "https://questionsmedicales.fr/author/Qin%20Shi",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China."
}
},
{
"@type": "Person",
"name": "Wei Wu",
"url": "https://questionsmedicales.fr/author/Wei%20Wu",
"affiliation": {
"@type": "Organization",
"name": "Center for Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University Pudong Medical Centre, Shanghai 201399, China."
}
},
{
"@type": "Person",
"name": "Lesheng Teng",
"url": "https://questionsmedicales.fr/author/Lesheng%20Teng",
"affiliation": {
"@type": "Organization",
"name": "Department of Biopharmaceutics, School of Life Sciences, Jilin University, Changchun, Jilin, China."
}
},
{
"@type": "Person",
"name": "Jyothsna Manikkath",
"url": "https://questionsmedicales.fr/author/Jyothsna%20Manikkath",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka State, 576104, India."
}
},
{
"@type": "Person",
"name": "Muhammad Fahad",
"url": "https://questionsmedicales.fr/author/Muhammad%20Fahad",
"affiliation": {
"@type": "Organization",
"name": "Particle Design and Drug Delivery Laboratory, Faculty of Pharmacy, Gomal University, Dera Ismail Khan, 29050, Khyber Pakhtunkhwa, Pakistan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Nanotechnology-based mucoadhesive and mucus-penetrating drug-delivery systems for transbuccal drug delivery.",
"datePublished": "2023-10-13",
"url": "https://questionsmedicales.fr/article/37830424",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2217/nnm-2023-0180"
}
},
{
"@type": "ScholarlyArticle",
"name": "Polysaccharides gums in drug delivery systems: A review.",
"datePublished": "2023-09-21",
"url": "https://questionsmedicales.fr/article/37741484",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijbiomac.2023.127020"
}
},
{
"@type": "ScholarlyArticle",
"name": "Macrocycle-Based Supramolecular Drug Delivery Systems: A Concise Review.",
"datePublished": "2024-08-12",
"url": "https://questionsmedicales.fr/article/39202907",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules29163828"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nano-scale drug delivery systems for luteolin: advancements and applications.",
"datePublished": "2023-12-06",
"url": "https://questionsmedicales.fr/article/37986608",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d3tb01753b"
}
},
{
"@type": "ScholarlyArticle",
"name": "Engineered therapeutic proteins for sustained-release drug delivery systems.",
"datePublished": "2023-09-16",
"url": "https://questionsmedicales.fr/article/37717712",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.actbio.2023.09.018"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Thérapeutique",
"item": "https://questionsmedicales.fr/mesh/D013812"
},
{
"@type": "ListItem",
"position": 3,
"name": "Traitement médicamenteux",
"item": "https://questionsmedicales.fr/mesh/D004358"
},
{
"@type": "ListItem",
"position": 4,
"name": "Systèmes de délivrance de médicaments",
"item": "https://questionsmedicales.fr/mesh/D016503"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Systèmes de délivrance de médicaments - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Systèmes de délivrance de médicaments",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-08-26",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Systèmes de délivrance de médicaments",
"description": "Comment évaluer l'efficacité d'un système de délivrance ?\nQuels tests sont utilisés pour analyser les systèmes de délivrance ?",
"url": "https://questionsmedicales.fr/mesh/D016503#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Systèmes de délivrance de médicaments",
"description": "Quels symptômes peuvent indiquer un problème de délivrance ?\nComment reconnaître une mauvaise absorption du médicament ?",
"url": "https://questionsmedicales.fr/mesh/D016503#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Systèmes de délivrance de médicaments",
"description": "Comment prévenir les complications liées à la délivrance ?\nQuels conseils pour une bonne utilisation des systèmes de délivrance ?",
"url": "https://questionsmedicales.fr/mesh/D016503#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Systèmes de délivrance de médicaments",
"description": "Quels sont les types de systèmes de délivrance ?\nComment les nanoparticules améliorent-elles la délivrance ?",
"url": "https://questionsmedicales.fr/mesh/D016503#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Systèmes de délivrance de médicaments",
"description": "Quelles complications peuvent survenir avec les systèmes injectables ?\nComment gérer les effets secondaires des systèmes de délivrance ?",
"url": "https://questionsmedicales.fr/mesh/D016503#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Systèmes de délivrance de médicaments",
"description": "Quels facteurs augmentent le risque d'échec de délivrance ?\nComment le mode de vie influence-t-il la délivrance des médicaments ?",
"url": "https://questionsmedicales.fr/mesh/D016503#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un système de délivrance ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par des études cliniques mesurant la biodisponibilité et l'effet thérapeutique."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour analyser les systèmes de délivrance ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests in vitro et in vivo, comme la libération contrôlée et la pharmacocinétique, sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème de délivrance ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme une douleur persistante ou une réaction allergique peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une mauvaise absorption du médicament ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme l'inefficacité du traitement ou des effets secondaires inattendus peuvent indiquer une mauvaise absorption."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées à la délivrance ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance régulière et l'éducation des patients sur l'utilisation correcte des systèmes sont essentielles."
}
},
{
"@type": "Question",
"name": "Quels conseils pour une bonne utilisation des systèmes de délivrance ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivre les instructions du médecin et respecter les horaires de prise sont cruciaux."
}
},
{
"@type": "Question",
"name": "Quels sont les types de systèmes de délivrance ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les systèmes incluent les formes orales, injectables, transdermiques et implantables."
}
},
{
"@type": "Question",
"name": "Comment les nanoparticules améliorent-elles la délivrance ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les nanoparticules permettent une délivrance ciblée et améliorent la solubilité des médicaments."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les systèmes injectables ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections, des hématomes ou des réactions allergiques peuvent survenir avec les injections."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets secondaires des systèmes de délivrance ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est important de consulter un médecin pour ajuster le traitement ou changer de système."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'échec de délivrance ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme l'obésité, l'âge avancé et les comorbidités peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il la délivrance des médicaments ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sédentaire ou une mauvaise alimentation peuvent affecter l'absorption des médicaments."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 08/06/2026
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
Publications dans "Systèmes de délivrance de médicaments" :
2 publications dans cette catégorie
Affiliations :
Center for Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University Pudong Medical Centre, Shanghai 201399, China.
Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai 201203, China.
Publications dans "Systèmes de délivrance de médicaments" :
2 publications dans cette catégorie
Affiliations :
Department of Biopharmaceutics, School of Life Sciences, Jilin University, Changchun, Jilin, China.
Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Changchun, Jilin, China.
Publications dans "Systèmes de délivrance de médicaments" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka State, 576104, India.
Publications dans "Systèmes de délivrance de médicaments" :
2 publications dans cette catégorie
Affiliations :
Particle Design and Drug Delivery Laboratory, Faculty of Pharmacy, Gomal University, Dera Ismail Khan, 29050, Khyber Pakhtunkhwa, Pakistan.
Publications dans "Systèmes de délivrance de médicaments" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacy, Faculty of Medical and Health Sciences, University of Poonch, Rawalakot, Azad Jammu and Kashmir, Pakistan.
Publications dans "Systèmes de délivrance de médicaments" :
2 publications dans cette catégorie
Affiliations :
Guangdong Institute for Drug Control, NMPA Key Laboratory for Quality Control and Evaluation of Pharmaceutical Excipients, Guangzhou 510660, China.
Publications dans "Systèmes de délivrance de médicaments" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutics and Pharmaceutics & Pharmaceutical Technology, University of Lagos, Lagos, Nigeria. Electronic address: omkolawole@unilag.edu.ng.
Publications dans "Systèmes de délivrance de médicaments" :
1 publication dans cette catégorie
Affiliations :
UCL School of Pharmacy, University College London, 29-39, Brunswick Square, London WC1N 1AX, United Kingdom; School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, United Kingdom. Electronic address: michael.t.cook@ucl.ac.uk.
Publications dans "Systèmes de délivrance de médicaments" :
1 publication dans cette catégorie
Affiliations :
Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan 7718175911, Iran. Electronic address: s.ebrahimalavi@gmail.com.
Publications dans "Systèmes de délivrance de médicaments" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Al-Dawadmi Campus, Al-Dawadmi 11961, Saudi Arabia.
Publications dans "Systèmes de délivrance de médicaments" :
1 publication dans cette catégorie
Affiliations :
Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan 7718175911, Iran.
Publications dans "Systèmes de délivrance de médicaments" :
1 publication dans cette catégorie
Affiliations :
School of Pharmacy, Fudan University, Shanghai 201203, PR China.
Publications dans "Systèmes de délivrance de médicaments" :
1 publication dans cette catégorie
Affiliations :
Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan 7718175911, Iran. Electronic address: ebrahimi@rums.ac.ir.
Publications dans "Systèmes de délivrance de médicaments" :
1 publication dans cette catégorie
Affiliations :
Jain PharmaBiotech, Basel, Switzerland. jain@pharmabiotech.ch.
Publications dans "Systèmes de délivrance de médicaments" :
1 publication dans cette catégorie
Affiliations :
Graduate School of Natural and Applied Sciences, Department of Molecular Biology and Genetics, Muğla Sıtkı Koçman University, Muğla, Turkey.
Publications dans "Systèmes de délivrance de médicaments" :
1 publication dans cette catégorie
Affiliations :
Graduate School of Natural and Applied Sciences, Department of Molecular Biology and Genetics, Muğla Sıtkı Koçman University, Muğla, Turkey.
Muğla Vocational School, Chemistry and Chemical Processing Technology Department, Muğla Sıtkı Koçman University, Muğla, Turkey.
Publications dans "Systèmes de délivrance de médicaments" :
1 publication dans cette catégorie
Affiliations :
Health Science Institute, Istanbul University, 34126 Istanbul, Türkiye.
Department of Pharmaceutical Technology, Faculty of Pharmacy, Istanbul University-Cerrahpaşa, 34500 Istanbul, Türkiye.
Department of Pharmaceutical Technology, Faculty of Pharmacy, Istanbul Health and Technology University, 34445 Istanbul, Türkiye.
Publications dans "Systèmes de délivrance de médicaments" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Technology, Faculty of Pharmacy, Istanbul Health and Technology University, 34445 Istanbul, Türkiye.
Publications dans "Systèmes de délivrance de médicaments" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Technology, Faculty of Pharmacy, Istanbul Health and Technology University, 34445 Istanbul, Türkiye.
Publications dans "Systèmes de délivrance de médicaments" :
Buccal drug-delivery systems present a promising approach for the drug delivery to the buccal mucosa, addressing oral cavity-specific problems, enabling systemic delivery and minimizing adverse effect...
For the drug delivery system, drug carriers' selection is critical to the drug's success in reaching the desired target. Drug carriers from natural biopolymers are preferred over synthetic materials d...
Efficient delivery of therapeutic agents to the lesion site or specific cells is an important way to achieve "toxicity reduction and efficacy enhancement". Macrocycles have always provided many novel ...
Luteolin (Lu) is a naturally occurring flavonoid compound with a diverse array of pharmacological activities, including anti-tumor, anti-inflammatory, antibacterial, and neuroprotective properties. Ho...
Proteins play a vital role in diverse biological processes in the human body, and protein therapeutics have been applied to treat different diseases such as cancers, genetic disorders, autoimmunity, a...
Nano-based drug delivery systems are increasingly used for diagnosis, prevention and treatment of several diseases, thanks to several beneficial properties, including the ability to target specific ce...
Self-nanoemulsifying drug delivery systems (SNEDDS) have been used to improve the oral bioavailability of various drugs. In the current study, apigenin was developed as SNEDDS to solve its dissolution...
Natural products are potential sources of anticancer components. Among various species, the lipophilic extract of the...
The histochemical analysis showed the presence of lipophilic compounds in the leaves and stems. The major compound in the VALE was oleanolic acid, followed by lupeol acetate and ursolic acid. SNEDDS w...
This is the first histochemistry analysis of...
Today, macromolecular compounds such as microRNAs (miRNAs) are becoming more and more widespread as leading therapeutics. However, their application is limited mostly due to their poor stability, limi...
Cancer is a leading cause of the death worldwide. However, the conventional cancer therapy still suffers from several limitations, such as systemic side effects, poor efficacy, and patient compliance ...